Within this subset of our cohort, we found no differences in IL-1β, IL-6, or IL-8 secretion between CF subjects who were taking prescribed modulators and CF subjects who were not (Supplementary Fig. S3a–c). Here, CXCL8 is linked to cystic fibrosis.